EGFR and non-small cell lung carcinoma: Similar distribution of EGFR subtypes was previously seen in clinical studies from South Korea.5 Patients with SQ NSCLC were not generally tested for biomarkers, and those who were tested harbored WT genes for potentially druggable biomarkers.